|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 31/426 | (2006.01) | ||
| A61P 9/06 | (2006.01) |
| (11) | Number of the document | 2278960 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09721703.8 |
| Date of filing the European patent application | 2009-03-12 | |
| (97) | Date of publication of the European application | 2011-02-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation | 2017-02-10 |
| (86) | Number | PCT/IB2009/051030 |
| Date | 2009-03-12 |
| (87) | Number | WO 2009/115954 |
| Date | 2009-09-24 |
| (30) | Number | Date | Country code |
| PCT/IB2008/0509 | 2008-03-17 | WO |
| (72) |
BROSSARD, Patrick, CH
DINGEMANSE, Jasper, CH
NAYLER, Oliver, CH
SCHERZ, Michael, CH
STEINER, Beat, CH
|
| (73) |
Laboratoires Juvise Pharmaceuticals,
149, Boulevard Bataille de Stalingrad, 69100 Villeurbanne,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | S1P1 receptoriaus selektyvaus agonisto dozavimo režimas |
| DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST |
| Payment date | Validity (years) | Amount | |
| 2026-02-20 | 18 | 347.00 EUR |
| 2027-03-12 |